There is a large pipeline of CAR-T cell therapies for diffuse large B-cell lymphoma
Chimeric antigen receptor T (CAR-T) cells are a form of ACT in which cells are engineered to express a synthetic…
By
Chimeric antigen receptor T (CAR-T) cells are a form of ACT in which cells are engineered to express a synthetic…
ByAlnylam aims to develop a therapy that targets the INHBE gene and reduces the overall risk of T2D and coronary…
ByWorking with a contract manufacturing organization (CMO) in the pursuit of bringing a new product to market can deliver a…
An incomplete understanding of the disease, low incidence, and a rapid progression hamper the development of therapies for TSEs.
ByWith public demand for new options, the male contraceptive research field is advancing despite persistent challenges.
ByElectronic health records (EHRs) are expected to drive big changes in the provision of healthcare and clinical research delivery.
ByTo overcome the growing threat posed by antimicrobial resistance, a variety of approaches must be taken.
ByA total of 127 planned schizophrenia clinical trials are planned to be held over the coming years.
ByThank you for subscribing to Pharmaceutical Technology